Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population-based analysis

Derek R. Johnson, Heather E. Leeper, Joon H. Uhm

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint Dive into the research topics of 'Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population-based analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences